
Michael B Kastan MD
Professor of Pharmacology and Cancer Biology, Duke University School of Medicine and Executive Director, Duke Cancer Institute
Join to View Full Profile
2100 Erwin RdDurham, NC 27705
Phone+1 919-684-8111
Fax+1 919-620-4921
Dr. Kastan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Johns Hopkins UniversityFellowship, Pediatric Hematology/Oncology, 1986 - 1989
Johns Hopkins UniversityResidency, Pediatrics, 1984 - 1986
Washington University in St. LouisPh.D., 1977 - 1984
Washington University in St. Louis School of MedicineClass of 1984
University of North Carolina SystemB.S., Chemistry, with Highest Honors, 1973 - 1977
Certifications & Licensure
NC State Medical License 2011 - 2026
TN State Medical License 1998 - 2013- American Board of PediatricsSubspeciatly Board of Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Elected Fellow of the AACR Academy American Association for Cancer Research, 2017
- Elected National Academy of Sciences National Academy of Sciences, 2016
- Elected Fellow American Association for the Advancement of Science, 2013
Publications & Presentations
PubMed
- ATM interaction with GRP94 modulates oncogenic receptor expression and signaling and microglial activation.Paige E Burrell, Donald E Fleenor, Olivia M Nicholson, Changjuan Shao, Michael B Kastan
Proceedings of the National Academy of Sciences of the United States of America. 2025-12-30 - 14 citationsA Novel Dual ATM/DNA-PK Inhibitor, XRD-0394, Potently Radiosensitizes and Potentiates PARP and Topoisomerase I Inhibitors.Tona M Gilmer, Chun-Hsiang Lai, Kexiao Guo, Katherine Deland, Kathleen A Ashcraft
Molecular Cancer Therapeutics. 2024-06-04 - 4 citationsParticipation of ATM, SMG1, and DDX5 in a DNA Damage-Induced Alternative Splicing Pathway.Jennifer J McCann, Donald E Fleenor, Jing Chen, Chun-Hsiang Lai, Thomas E Bass
Radiation Research. 2023-04-01
Journal Articles
- The DNA Damage Response: Implications for Tumor Responses to Radiation and ChemotherapyGoldstein M, Kastan MB, Annual Review of Medicine, 1/1/2015
- Repair versus checkpoint functions of Brca1 are differentially regulated by site of chromatin bindingGoldstein M, Kastan MB, Cancer Res, 1/1/2015
- ATM Functions at the Peroxisome to Induce Pexophagy in Response to ROSZhang J,, Tripathi DN, Jing, J, Alexander A, Kim J, Powell RT, Dere R, Tait-Mulder J, Lee J-H, Paull TT, Pandita RK, Charaka VK, Pandita TK, Kastan MB, Walker CL, Nature Cell Biology, 1/1/2015
Books/Book Chapters
Press Mentions
Anonymous Donor Gives $50 Million to Duke for Proton Beam TherapyDecember 11th, 2024
Developing New Tools to Fight CancerOctober 17th, 2022- Developing New Tools to Fight CancerOctober 17th, 2022
Grant Support
- Strengthening LMIC Institutional Capacity for Direct NIH Grant Administration through the East Africa Cancer CollaborationDUKE UNIVERSITY1997–2029
- Chromatin Modulation Associated With DNA Breakage And Repair In Human CellsNational Cancer Institute2011–2012
- ATM, Reactive Oxygen, And Cellular Responses To HypoxiaNational Cancer Institute2011–2012
- Cellular Stress Response Signaling PathwaysNational Institute Of Environmental Health Sciences2011
- Chromatin Modulation Associated With DNA Breakage And Repair In Human CellsNational Cancer Institute2011
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









